Endocrine Abstracts

Background: Serum inflammation-based scores can predict clinical outcomes in several cancer types, including adrenocortical carcinoma (ACC). They may also be altered in benign adrenocortical tumours and correlate with cortisol excess. It is unclear whether the inflammation-based score alterations in ACC reflects malignancy, steroid excess, or both.Methods: A total of 490 patients were included (429 [87.6%] with adrenocortical adenoma [ACA] and 61 [12.4%]...